Compugen Ltd. ( CGEN) - Key Metrics
CGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.71 | $0.60 | ? | ? |
| 2025Q3 | $0.02 | -$0.07 | ? | ? |
| 2025Q2 | $0.01 | -$0.08 | ? | ? |
| 2025Q1 | $0.02 | -$0.08 | ? | ? |
CGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 0.63 |
| 2025Q3 | ? | -4.93 |
| 2025Q2 | ? | -5.67 |
| 2025Q1 | ? | -4.69 |
CGEN
Price: $2.12
52 week price:
Earnings Per Share: 0.38 USD
P/E Ratio: 7.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 1.0 million
Ebitda: -10.0 millionMarket Capitalization: 264.8 million